- Home
- APLM vs IBO Comparison
APLM vs IBO Comparison
Compare APLM & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- IBO
- Stock Information
- Founded
- APLM 2016
- IBO 2018
- Country
- APLM United States
- IBO United States
- Employees
- APLM N/A
- IBO N/A
- Industry
- APLM Blank Checks
- IBO
- Sector
- APLM Finance
- IBO
- Exchange
- APLM Nasdaq
- IBO NYSE
- Market Cap
- APLM 6.9M
- IBO 5.8M
- IPO Year
- APLM N/A
- IBO 2024
- Fundamental
- Price
- APLM $6.49
- IBO $0.65
- Analyst Decision
- APLM
- IBO
- Analyst Count
- APLM 0
- IBO 0
- Target Price
- APLM N/A
- IBO N/A
- AVG Volume (30 Days)
- APLM 7.8K
- IBO 23.3M
- Earning Date
- APLM 08-13-2025
- IBO 08-23-2025
- Dividend Yield
- APLM N/A
- IBO N/A
- EPS Growth
- APLM N/A
- IBO N/A
- EPS
- APLM N/A
- IBO N/A
- Revenue
- APLM $198,000.00
- IBO N/A
- Revenue This Year
- APLM $415.15
- IBO N/A
- Revenue Next Year
- APLM N/A
- IBO N/A
- P/E Ratio
- APLM N/A
- IBO N/A
- Revenue Growth
- APLM N/A
- IBO N/A
- 52 Week Low
- APLM $4.47
- IBO $0.36
- 52 Week High
- APLM $35.98
- IBO $6.17
- Technical
- Relative Strength Index (RSI)
- APLM 47.85
- IBO N/A
- Support Level
- APLM $6.21
- IBO N/A
- Resistance Level
- APLM $6.80
- IBO N/A
- Average True Range (ATR)
- APLM 0.52
- IBO 0.00
- MACD
- APLM 0.00
- IBO 0.00
- Stochastic Oscillator
- APLM 51.61
- IBO 0.00
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.